Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis. [electronic resource]
Producer: 20200622Description: 1360-1369 p. digitalISSN:- 1474-5488
- Aminopyridines -- administration & dosage
- Anastrozole -- administration & dosage
- Androstadienes -- administration & dosage
- Antineoplastic Agents, Hormonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Benzimidazoles -- administration & dosage
- Bevacizumab -- administration & dosage
- Breast Neoplasms -- drug therapy
- Clinical Trials, Phase II as Topic
- Clinical Trials, Phase III as Topic
- Everolimus -- administration & dosage
- Female
- Fulvestrant -- administration & dosage
- Humans
- Letrozole -- administration & dosage
- Network Meta-Analysis
- Paclitaxel -- administration & dosage
- Piperazines -- administration & dosage
- Postmenopause
- Progression-Free Survival
- Purines -- administration & dosage
- Pyridines -- administration & dosage
- Randomized Controlled Trials as Topic
- Receptor, ErbB-2 -- metabolism
- Receptors, Estrogen -- metabolism
- Receptors, Progesterone -- metabolism
No physical items for this record
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.